Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAMA: Fenofibrate and Metformin for Atherogenic Dyslipidemia
NCT00400231Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate, metformin in metabolic syndrome, atherogenic dyslipidemia (AD), insulin resistance (IR), sponsored by University of Pennsylvania. Started Aug 2005; status: completed.
02
Drugs
fenofibratemetformin
03
Conditions
metabolic syndromeatherogenic dyslipidemia (AD)insulin resistance (IR)
Beyond the preview
Go deeper on NCT00400231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400231.